80 results on '"Netsch, C."'
Search Results
2. Harnableitung beim alten Patienten (80+)
- Author
-
Oswald, D., Herrmann, T. R. W., Netsch, C., Becker, B., Hatiboglu, G., Homberg, R., Klein, J. T., Lehrich, K., Miernik, A., Olbert, P., Schöb, D. S., Sievert, K. D., Herrmann, J., Gross, A. J., Pallauf, M., Deininger, S., Ramesmayer, C., Peters, J., and Lusuardi, L.
- Published
- 2024
- Full Text
- View/download PDF
3. Correction: Consensus statement addressing controversies and guidelines on pediatric urolithiasis
- Author
-
Güven, S., Tokas, T., Tozsin, A., Haid, B., Lendvay, T. S., Silay, S., Mohan, V. C., Cansino, J. R., Saulat, S., Straub, M., Bujons Tur, A., Akgül, B., Samotyjek, J., Lusuardi, L., Ferretti, S., Cavdar, O. F., Ortner, G., Sultan, S., Choong, S., Micali, S., Saltirov, I., Sezer, A., Netsch, C., de Lorenzis, E., Cakir, O. O., Zeng, G., Gozen, A. S., Bianchi, G., Jurkiewicz, B., Knoll, T., Rassweiler, J., Ahmed, K., and Sarica, K.
- Published
- 2024
- Full Text
- View/download PDF
4. Consensus statement addressing controversies and guidelines on pediatric urolithiasis
- Author
-
Güven, S., Tokas, T., Tozsin, A., Haid, B., Lendvay, T. S., Silay, S., Mohan, V. C., Cansino, J. R., Saulat, S., Straub, M., Tur, A. Bujons, Akgül, B., Samotyjek, J., Lusuardi, L., Ferretti, S., Cavdar, O. F., Ortner, G., Sultan, S., Choong, S., Micali, S., Saltirov, I., Sezer, A., Netsch, C., de Lorenzis, E., Cakir, O. O., Zeng, G., Gozen, A. S., Bianchi, G., Jurkiewicz, B., Knoll, T., Rassweiler, J., Ahmed, K., and Sarica, K.
- Published
- 2024
- Full Text
- View/download PDF
5. The long-term learning curve of holmium laser enucleation of the prostate (HoLEP) in the en-bloc technique: a single surgeon series of 500 consecutive cases
- Author
-
Wenk, M. J., Hartung, F. O., Egen, L., Netsch, C., Kosiba, M., Grüne, B., and Herrmann, Jonas
- Published
- 2024
- Full Text
- View/download PDF
6. Hydrozele
- Author
-
Filmar, S., Gross, A. J., Hook, S., Rosenbaum, C. M., Netsch, C., and Becker, B.
- Published
- 2024
- Full Text
- View/download PDF
7. Update Harnleiterrekonstruktion 2024
- Author
-
Hook, S., Gross, A. J., Netsch, C., Becker, B., Filmar, S., Vetterlein, M. W., Kluth, L. A., and Rosenbaum, C. M.
- Published
- 2024
- Full Text
- View/download PDF
8. Hauterscheinungen des männlichen Genitals
- Author
-
Hook, S., Gross, A. J., Becker, M., Netsch, C., Rosenbaum, C., and Becker, B.
- Published
- 2023
- Full Text
- View/download PDF
9. Aufbereitung von Medizinprodukten in der urologischen Praxis
- Author
-
Ebner, W., Bauer, M., Sigle, A., Miernik, A., Becker, B., Lehrich, K., Klein, J.-T., Lusuardi, L., Gross, A. J., Herrmann, T. R. W., Frede, T., Siegsmund, M., Netsch, C., Gratzke, C., and Schoeb, D. S.
- Published
- 2023
- Full Text
- View/download PDF
10. Neues Therapiekonzept der Darmverletzung nach perkutaner Nephrolitholapaxie
- Author
-
Hook, S., Netsch, C., Rosenbaum, C., Baumbach, R., Gross, A. J., Ozimek, T., and Becker, B.
- Published
- 2022
- Full Text
- View/download PDF
11. Sicherheit und Effizienz der en bloc vs. konventionellen transurethralen Resektion von Blasentumoren: eine Metaanalyse und systematic Review
- Author
-
Oswald, D., Pallauf, P., Deininger, S., Herrmann, T. R. W., Netsch, C., Becker, B., Fiedler, M., Haecker, A., Homberg, R., Klein, J. T., Lehrich, K., Miernik, A., Olbert, P., Schöb, D. S., Sievert, K. D., Gross, A. J., Westphal, J., and Lusuardi, L.
- Published
- 2022
- Full Text
- View/download PDF
12. Transurethrale Resektion von Blasentumoren (TUR-B)
- Author
-
Oswald, D., Pallauf, M., Herrmann, T. R. W., Netsch, C., Becker, B., Lehrich, K., Miernik, A., Schöb, D. S., Sievert, K. D., Gross, A. J., Westphal, J., Lusuardi, L., and Deininger, S.
- Published
- 2022
- Full Text
- View/download PDF
13. Update on ureteral reconstruction 2024
- Author
-
Hook, S., primary, Gross, A. J., additional, Netsch, C., additional, Becker, B., additional, Filmar, S., additional, Vetterlein, M. W., additional, Kluth, L. A., additional, and Rosenbaum, C. M., additional
- Published
- 2023
- Full Text
- View/download PDF
14. Auf dem Weg zur rückstandsfreien Steinsanierung nach ureteroskopischer Laserlithotripsie - die Hydrogelmethode
- Author
-
Amiel, T, Straub, M, Neisius, A, Netsch, C, Secker, A, Fisang, C, Grunwald, I, Amiel, T, Straub, M, Neisius, A, Netsch, C, Secker, A, Fisang, C, and Grunwald, I
- Published
- 2023
15. Auf dem Weg zur rückstandsfreien Steinsanierung nach ureteroskopischer Laserlithotripsie - die Hydrogelmethode
- Author
-
Klorek, T, Amiel, T, Straub, M, Netsch, C, Secker, A, Neisius, A, Fisang, C, Klorek, T, Amiel, T, Straub, M, Netsch, C, Secker, A, Neisius, A, and Fisang, C
- Published
- 2023
16. Transurethrale Resektion von Blasentumoren (TUR-B)
- Author
-
Oswald, D., Pallauf, M., Herrmann, T. R. W., Netsch, C., Becker, B., Lehrich, K., Miernik, A., Schöb, D. S., Sievert, K. D., Gross, A. J., Westphal, J., Lusuardi, L., and Deininger, S.
- Abstract
Die transurethrale Resektion von Blasengewebe (TUR-B) ist für die Diagnostik und Therapie bei Blasentumoren indiziert. Diese werden fragmentiert mittels diathermaler Schlinge abgetragen. Der Wundgrund wird zur Blutstillung koaguliert. Zu achten ist auf eine ausreichende Schnitttiefe, sodass die Detrusormuskulatur erfasst ist. Postoperativ kann zur Rezidivprophylaxe eine intravesikale Single-shot-Chemotherapie verabreicht werden. Methoden zur verbesserten Tumorvisualisation (insbesondere photodynamische Diagnostik) helfen, besonders bei multilokulärem Befund oder Carcinoma in situ (CIS) bessere Detektionsraten zu erreichen sowie das Rezidiv- und Progressionsrisiko zu senken. In Abhängigkeit von der Histologie ergibt sich das weitere Vorgehen: bei nicht muskelinvasivem Blasenkarzinom Nachsorge, adjuvante Instillationstherapie mittels Chemotherapie oder Bacillus Calmette-Guérin (BCG), die Nachresektion („second look TUR-B“), die Frühzystektomie oder bei muskelinvasivem Blasenkarzinom die Zystektomie oder (onkologisch nachrangig) die trimodale Therapie mit erneuter TUR‑B, Radiotherapie und Chemotherapie. Mögliche Komplikationen im Rahmen der TUR‑B sind v. a. Nachblutung mit Blasentamponade, extra- oder intraperitoneale Blasenperforation oder Infektionen des Urogenitaltrakts.
- Published
- 2024
- Full Text
- View/download PDF
17. Sicherheit und Effizienz der en bloc vs. konventionellen transurethralen Resektion von Blasentumoren: eine Metaanalyse und systematic Review
- Author
-
Oswald, D., Pallauf, P., Deininger, S., Herrmann, T. R. W., Netsch, C., Becker, B., Fiedler, M., Haecker, A., Homberg, R., Klein, J. T., Lehrich, K., Miernik, A., Olbert, P., Schöb, D. S., Sievert, K. D., Gross, A. J., Westphal, J., and Lusuardi, L.
- Abstract
Hintergrund: Die transurethrale En-bloc-Resektion von Blasentumoren (ERBT) ist eine Alternative zur konventionellen transurethralen Resektion von Blasentumoren (TURB). Sie könnte dazu beitragen bekannte Probleme der Standardmethode wie fehlenden Detrusormuskel im Präparat, hohe Nachresektions- sowie Rezidivraten zu verbessern. Ziel: Die Analyse der aktuellen Datenlage zur ERBT in Bezug auf Effektivität und Sicherheit im Vergleicht zur TURB. Datenquelle: PubMed. Methode: Zwei unabhängige Autoren identifizierten Studien basierend auf den Einschlusskriterien sowie den Schlüsselwörtern. Ein dritter Autor wurde bei Unstimmigkeiten zur Entscheidungsfindung involviert. Screening Keywords: ERBT, en bloc transurethral resection of bladder tumor, en bloc TURBT. Eine Metaanalyse von 13 Studien wurde durchgeführt. Effektgrößen wurden mittels Odds Ratios und mittleren Differenzen samt den zugehörigen zweiseitigen 95 %-Konfidenzintervallen geschätzt. Ergebnisse: Die behandelten Studien untersuchten ein homogenes Kollektiv in Bezug auf Tumorgröße, Multiplizität und Stadium. Die Operationszeit zeigte sich nicht signifikant verschieden zwischen den Methoden. Signifikante Unterschiede bestanden in Hospitalisierungs- und Kathetereinliegedauer zugunsten der ERBT. Die Daten in Bezug auf Komplikationsraten zeigen keine sicheren Unterschiede auf. In der ERBT-Gruppe konnte signifikant mehr Detrusormuskel im Präparat nachgewiesen werden. Keine Unterschiede ergaben sich in der Rezidivrate bei einem Follow-up bis 2 Jahre. Schlussfolgerung: Die ERBT ist eine sichere Alternative zur konventionellen TURB mit vielversprechenden Möglichkeiten bezüglich der effektiven Resektion von Detrusormuskulatur. Mehr Daten aus randomisierten kontrollierten Studien zu Rezidivraten, unterschiedlichen Energiequellen und Resektionstechniken sowie freien Resektionsrändern sind notwendig um den Stellenwert der Methode klar einzuordnen.
- Published
- 2024
- Full Text
- View/download PDF
18. Analysis of morbidity and mortality after retrograde intrarenal surgery in patients with renal calculi: Evaluation of 146,189 patients from a nationwide German database
- Author
-
Becker, B., primary, Schulz, C., additional, Hermann, T., additional, Rosenbaum, C., additional, Gross, A.J., additional, König, H., additional, and Netsch, C., additional
- Published
- 2022
- Full Text
- View/download PDF
19. A1030 - Analysis of morbidity and mortality after retrograde intrarenal surgery in patients with renal calculi: Evaluation of 146,189 patients from a nationwide German database
- Author
-
Becker, B., Schulz, C., Hermann, T., Rosenbaum, C., Gross, A.J., König, H., and Netsch, C.
- Published
- 2022
- Full Text
- View/download PDF
20. V123 - Hybrid thulium laser incision in bladder neck contracture: Surgical technique and early outcomes.
- Author
-
Rosenbaum, C.M., Netsch, C., Becker, B., Filmar, S., Gross, A.J., and Bruchbacher, A.
- Subjects
- *
BLADDER obstruction , *THULIUM , *OPERATIVE surgery , *LASERS - Published
- 2023
- Full Text
- View/download PDF
21. A1069 - On the way to residue-free stone fragment removal after ureteroscopic laser lithotripsy - Significance of the hydrogel method.
- Author
-
Amiel, T., Straub, M., Neisius, A., Netsch, C., Secker, A., Fisang, C., and Grunwald, I.
- Subjects
- *
LASER lithotripsy , *HYDROGELS - Published
- 2023
- Full Text
- View/download PDF
22. High-throughput platform for label-free sorting of 3D spheroids using deep learning.
- Author
-
Sampaio da Silva C, Boos JA, Goldowsky J, Blache M, Schmid N, Heinemann T, Netsch C, Luongo F, Boder-Pasche S, Weder G, Pueyo Moliner A, Samsom RA, Marsee A, Schneeberger K, Mirsaidi A, Spee B, Valentin T, Hierlemann A, and Revol V
- Abstract
End-stage liver diseases have an increasing impact worldwide, exacerbated by the shortage of transplantable organs. Recognized as one of the promising solutions, tissue engineering aims at recreating functional tissues and organs in vitro . The integration of bioprinting technologies with biological 3D models, such as multi-cellular spheroids, has enabled the fabrication of tissue constructs that better mimic complex structures and in vivo functionality of organs. However, the lack of methods for large-scale production of homogeneous spheroids has hindered the upscaling of tissue fabrication. In this work, we introduce a fully automated platform, designed for high-throughput sorting of 3D spheroids based on label-free analysis of brightfield images. The compact platform is compatible with standard biosafety cabinets and includes a custom-made microscope and two fluidic systems that optimize single spheroid handling to enhance sorting speed. We use machine learning to classify spheroids based on their bioprinting compatibility. This approach enables complex morphological analysis, including assessing spheroid viability, without relying on invasive fluorescent labels. Furthermore, we demonstrate the efficacy of transfer learning for biological applications, for which acquiring large datasets remains challenging. Utilizing this platform, we efficiently sort mono-cellular and multi-cellular liver spheroids, the latter being used in bioprinting applications, and confirm that the sorting process preserves viability and functionality of the spheroids. By ensuring spheroid homogeneity, our sorting platform paves the way for standardized and scalable tissue fabrication, advancing regenerative medicine applications., Competing Interests: AlM is working at Kuglemeiers Ltd. developing and commercializing SP5D culture plates used in the context of this study. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2024 Sampaio da Silva, Boos, Goldowsky, Blache, Schmid, Heinemann, Netsch, Luongo, Boder-Pasche, Weder, Pueyo Moliner, Samsom, Marsee, Schneeberger, Mirsaidi, Spee, Valentin, Hierlemann and Revol.)
- Published
- 2024
- Full Text
- View/download PDF
23. [Follow-up after urinary diversion].
- Author
-
Netsch C, Filmar S, Hook S, Rosenbaum C, Gross AJ, and Becker B
- Subjects
- Humans, Cystectomy, Follow-Up Studies, Neoplasm Recurrence, Local, Postoperative Complications epidemiology, Postoperative Complications etiology, Urinary Bladder Neoplasms surgery, Urinary Bladder Neoplasms pathology, Urinary Diversion adverse effects, Urinary Diversion methods
- Abstract
Radical cystectomy is currently the standard of care for muscle-invasive bladder cancer. Different parts of the small and large intestines can be utilized for continent and incontinent urinary diversion. The postoperative follow-up after urinary diversion should consider functional, metabolic and oncological aspects. The functional follow-up of (continent) urinary diversion includes stenosis, emptying disorders or incontinence. The oncological follow-up should focus on the detection of local, urethral and upper tract recurrences as well as distant metastases. As 90% of the tumor recurrences occur during the first 3 years, a close follow-up should be carried out during this period. Metabolic disturbances, such as vitamin B12 and bile acid deficits, acidosis and disorders of calcium metabolism can also occur during long-term follow-up. The metabolic follow-up should consider the metabolic consequences of the parts of the intestines utilized for the urinary diversion., (© 2024. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF
24. [Rare case of leiomyosarcoma of the urinary bladder in a young man].
- Author
-
Filmar S, Gross AJ, Tonus C, Hook S, Rosenbaum CM, Becker B, Netsch C, and Gattenloehner P
- Subjects
- Humans, Male, Young Adult, Rare Diseases surgery, Rare Diseases pathology, Leiomyosarcoma pathology, Leiomyosarcoma surgery, Leiomyosarcoma diagnosis, Urinary Bladder Neoplasms surgery, Urinary Bladder Neoplasms pathology, Urinary Bladder Neoplasms diagnosis, Cystectomy
- Abstract
Leiomyosarcomas are rare, highly aggressive tumors of the urinary bladder. With approximately 200 cases reported in the literature, there is limited data on the prognosis and treatment of these neoplasms. Curative treatment approaches are primarily characterized by radical surgery, especially radical cystectomy. However, this procedure is associated with significant impairments in the quality of life for patients. This circumstance forms the basis for considering a curative treatment approach with partial cystectomy for a 19-year-old man with leiomyosarcoma of the urinary bladder., (© 2024. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF
25. Development of a Bladder Injury Classification System for Endoscopic Procedures: A Mixed-methods Study Involving Expert Consensus and Validation.
- Author
-
Akgül B, Tozsin A, Tokas T, Micali S, Herrmann T, Bianchi G, Fiori C, Altınkaya N, Ortner G, Knoll T, Lehrich K, Böhme A, Gadzhiev N, Omar M, Kartalas Goumas I, Romero Otero J, Aydın A, Lusuardi L, Netsch C, Khan A, Greco F, Dasgupta P, Tunc L, Rassweiler J, Serdar Gozen A, Ahmed K, and Güven S
- Abstract
Background and Objective: The widespread adoption and rapid integration of new technologies and techniques in endoscopic and laser bladder interventions, particularly endoscopic enucleation, have led to new types of bladder injuries. This underscores the need for an intraoperative injury classification system. This study aims to develop and validate the Bladder Injury Classification System for Endoscopic Procedures (BICEP), which standardizes the classification of complications and intervention requirements., Methods: This mixed-methods study involved experts from the European Association of Urology Section of Urotechnology to standardize and validate the BICEP classification system. An iterative process involving focus groups, expert surveys, and revisions assessed clarity, relevance, comprehensiveness, and practicality. Validity was confirmed through expert surveys conducted in two rounds for face and content validity, using a 5-point Likert scale to correlate ratings with expected outcomes., Key Findings and Limitations: The novel BICEP classification system categorizes bladder injuries into ten subcategories with scores ranging from 0 to 4, reflecting injury severity and management requirements. Face validity was demonstrated by a 95% consensus on the system's clarity, relevance, and comprehensiveness. Content validity was supported by high acceptance rates in expert surveys, with average scores of 4.53 and 4.58 in the first and second rounds, respectively. This demonstrates strong support for its applicability in clinical practice. However, the primary limitation is the lack of external validation., Conclusions and Clinical Implications: Our study demonstrates that the BICEP system is a robust and comprehensive classification system, with strong support for its face and content validity. The BICEP system is a proposal based on expert opinion, and additional studies are necessary to ensure its widespread adoption and efficacy., Patient Summary: Our study addressed the critical need for standardized classification in the increasingly widespread context of urology endoscopic technologies by focusing on intraoperative evaluation, reporting, and standardization of bladder injuries. This study provides a globally standardized basis for the classification and treatment of bladder injuries in urology endoscopic procedures., (Copyright © 2024 European Association of Urology. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
26. [Organ-preserving treatment for urothelial carcinoma of the upper urinary tract].
- Author
-
Rosenbaum CM, Netsch C, Filmar S, Hook S, Gross AJ, and Becker B
- Abstract
Urothelial carcinoma of the upper urinary tract is rare but the incidence is currently increasing in western countries. Radical nephroureterectomy has long been the standard treatment; however, it can lead to chronic kidney failure and also the necessity for dialysis. Therefore, organ-preserving treatment is now recommended for selected patients with low-risk tumors. The choice of treatment depends on the tumor characteristics, comorbidities and individual risk factors. Surgical options for organ preservation include ureterorenoscopy (URS), percutaneous treatment and partial ureteral resection. The URS is the most frequently used method for organ preservation. Photodynamic diagnostics (PDD) and narrow band imaging (NBI) can potentially also be used for tumor detection in the upper urinary tract. Conservative options such as topical treatment with mitomycin C or Bacillus Calmette-Guérin (BCG) and systemic treatment options are also possible., (© 2024. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF
27. Summary Paper on Underactive Bladder from the European Association of Urology Guidelines on Non-neurogenic Male Lower Urinary Tract Symptoms.
- Author
-
Baboudjian M, Hashim H, Bhatt N, Creta M, De Nunzio C, Gacci M, Herrmann T, Karavitakis M, Malde S, Moris L, Netsch C, Rieken M, Sakalis V, Schouten N, Tutolo M, and Cornu JN
- Subjects
- Humans, Male, Europe, Urodynamics, Lower Urinary Tract Symptoms therapy, Lower Urinary Tract Symptoms diagnosis, Lower Urinary Tract Symptoms physiopathology, Lower Urinary Tract Symptoms etiology, Practice Guidelines as Topic, Urinary Bladder, Underactive diagnosis, Urinary Bladder, Underactive etiology, Urinary Bladder, Underactive physiopathology, Urinary Bladder, Underactive therapy, Urology standards
- Abstract
Background and Objective: The European Association of Urology (EAU) Guidelines Panel on non-neurogenic male lower urinary tract symptoms (LUTS) aimed to develop a new subchapter on underactive bladder (UAB) in non-neurogenic men to inform health care providers of current best evidence and practice. Here, we present a summary of the UAB subchapter that is incorporated into the 2024 version of the EAU guidelines on non-neurogenic male LUTS., Methods: A systematic literature search was conducted from 2002 to 2022, and articles with the highest certainty evidence were selected. A strength rating has been provided for each recommendation according to the EAU Guideline Office methodology., Key Findings and Limitations: Detrusor underactivity (DU) is a urodynamic diagnosis defined as a contraction of reduced strength and/or duration, resulting in prolonged bladder emptying and/or failure to achieve complete bladder emptying within a normal time span. UAB is a terminology that should be reserved for describing symptoms and clinical features related to DU. Invasive urodynamics is the only widely accepted method for diagnosing DU. In patients with persistently elevated postvoid residual (ie, >300 ml), intermittent catheterization is indicated and preferred to indwelling catheters. Alpha-adrenergic blockers are recommended before more invasive techniques, but the level of evidence is low. In men with DU and concomitant benign prostatic obstruction (BPO), benign prostatic surgery should be considered only after appropriate counseling. In men with DU and no BPO, a test phase of sacral neuromodulation may be considered., Conclusions and Clinical Implications: The current text represents a summary of the new subchapter on UAB. For more detailed information, refer to the full-text version available on the EAU website (https://uroweb.org/guidelines/management-of-non-neurogenic-male-luts)., (Copyright © 2024 European Association of Urology. Published by Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
28. [Urinary diversion in old patients (80+ years)].
- Author
-
Oswald D, Herrmann TRW, Netsch C, Becker B, Hatiboglu G, Homberg R, Klein JT, Lehrich K, Miernik A, Olbert P, Schöb DS, Sievert KD, Herrmann J, Gross AJ, Pallauf M, Deininger S, Ramesmayer C, Peters J, and Lusuardi L
- Subjects
- Aged, 80 and over, Female, Humans, Male, Quality of Life, Cystectomy, Urinary Bladder Neoplasms surgery, Urinary Diversion methods
- Abstract
With increasing life expectancy there is also an increased need for the management of older (≥ 80 years) patients with the diagnosis of muscle-invasive bladder cancer. Radical cystectomy with urinary diversion is the state of the art treatment (with neoadjuvant chemotherapy, as long as the patient is fit enough). Choosing the best urinary diversion with respect to morbidity compared to functionality and quality of life remains a challenge in these patients. Physical age alone is not decisive for making a decision. A thorough preoperative assessment of medical features, physical and cognitive impairments is more important. Older patients are generally provided with an ileal conduit as an incontinent urinary diversion, as the intervention involves reduced operating times and complexity compared to continent urinary diversions; however, in the case of good health status with an adequate life expectancy and sufficient compliance, continent diversions may be considered even in aged candidates. In the case of multimorbid patients with a high perioperative risk, ureterostomy with permanent ureteric stents is an important alternative. Most importantly, a thorough preoperative counselling enables patients to reach an informed decision., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
29. Perioperative Outcomes and Complication Rates in Holmium Laser Enucleation of the Prostate Patients After Prior Prostate Biopsy-Does It Really Make a Difference? A Propensity Score Matched Analysis.
- Author
-
Hartung FO, Egen L, Grüne B, Netsch C, Patroi P, Kriegmair MC, von Hardenberg J, Rassweiler-Seyfried MC, Michel MS, Wenk MJ, and Herrmann J
- Subjects
- Humans, Male, Aged, Middle Aged, Retrospective Studies, Biopsy adverse effects, Treatment Outcome, Laser Therapy adverse effects, Laser Therapy methods, Propensity Score, Lasers, Solid-State therapeutic use, Prostate surgery, Prostate pathology, Postoperative Complications etiology, Prostatic Neoplasms surgery, Prostatic Neoplasms pathology
- Abstract
Introduction: Before holmium laser enucleation of the prostate (HoLEP), many patients have undergone short-term prostate biopsy (PB) to rule out the presence of prostate cancer. The aim of this study is to determine whether a short-term PB before HoLEP has an impact on the perioperative outcomes or complications of HoLEP. Methods: In total, 734 consecutive patients treated with HoLEP at a tertiary care university hospital between January 2021 and July 2023 were retrospectively enrolled. Patients who had PB within 6 months before HoLEP were matched to patients who underwent PB more than 6 months or had no PB before HoLEP using propensity score matching (PSM) based on age, prostate volume (PV), prostate-specific antigen (PSA), preoperative urinary tract infection (UTI), and surgeon. Perioperative parameters, such as operation time (OT), enucleation efficiency (EF), as well as complications according to the Satava classification, the Clavien-Dindo classification (CDC), and the Comprehensive Complication Index (CCI) were evaluated. Results: In total, 206 patients were matched. Age, PV, PSA, as well as the presence of a preoperative UTI and surgeons did not differ significantly between both groups after PSM. There were no significant differences in mean OT (75 vs. 81 minutes, p = 0.28) and EF (2.13 vs. 2.13 g/min, p = 0.99). No differences were noted regarding intraoperative (16 vs. 25, p = 0.16) or postoperative complications graded by CDC ( p = 0.53) and CCI ( p = 0.92). Conclusion: PB within 6 months preoperatively before HoLEP showed no effect on perioperative outcomes or intra- and postoperative complications.
- Published
- 2024
- Full Text
- View/download PDF
30. [Urethral reconstruction].
- Author
-
Rosenbaum CM, Netsch C, Gross AJ, and Becker B
- Subjects
- Humans, Male, Urologic Surgical Procedures, Male methods, Endoscopy methods, Urethral Stricture surgery, Urethral Stricture diagnostic imaging, Urethra surgery, Urethra diagnostic imaging, Plastic Surgery Procedures methods
- Abstract
A urethral stricture is an abnormal narrowing of the urethra due to spongiofibrosis of the urethral mucosa and the underlying corpus spongiosum. The diagnostics include uroflowmetry, sonography and radiology. For penile strictures the success rate of endoscopic treatment is low. Therefore, urethroplasty should always be performed, preferably using oral mucosa. Depending on the complexity, reconstruction must be carried out in one or multiple stages. For short bulbous strictures endoscopic treatment can primarily be carried out. In the case of recurrence urethroplasty should be carried out. The indications for urethral reconstruction are primarily given for long bulbous strictures. Depending on the length and extent of the stricture, a scar resection and end-to-end anastomosis, non-transsecting end-to-end anastomosis or augmentation urethroplasty can be performed. Perineal urethrostomy (the so-called boutonnière procedure) is a treatment option for patients with complex strictures or for patients who want a straightforward solution., (© 2024. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF
31. [Minimally-Invasive Surgical Techniques (MIST): Shedding Light on the Mist].
- Author
-
Netsch C, Gross AJ, Herrmann TR, Herrmann J, and Becker B
- Subjects
- Humans, Male, Transurethral Resection of Prostate methods, Postoperative Complications etiology, Prostatic Hyperplasia surgery, Prostatic Hyperplasia therapy, Minimally Invasive Surgical Procedures methods
- Abstract
As life expectancy increases and there is growing demand for BPH treatments, innovative technologies have been developed, allowing for swift recovery, symptom relief, low complication rates, and the possibility of performing procedures on an outpatient basis, often under local anaesthesia. This review aims to describe the outcomes of newly developed minimally-invasive surgical therapies (MIST) for BPH treatment in terms of functional voiding parameters and sexual function. These therapies are categorized into primarily ablative (Aquablation [Aquabeam]), non-ablative (Prostatic Urethral Lift (PUL, Urolift), temporary implantable devices [iTind]), and secondarily ablative procedures (convective water vapor ablation, Rezum, Prostate Artery Embolization [PAE]). All MIST technologies have advanced the medical care of patients with BPH while preserving ejaculation. However, there is a shortage of long-term data specifically addressing re-intervention rates and the preservation of functional voiding parameters. Although there is promising data from regulatory trials and randomized studies, all MIST therapies are potentially associated with severe complications. Patients considering such methods must be thoroughly informed about their inferiority compared with established transurethral procedures like TUR-P and enucleation., Competing Interests: C. Netsch: R. Wolf (Consultant, Proctor); B. Becker: R. Wolf (Consultant, Proctor); A. Gross: R. Wolf (Consultant, Proctor); T. R.W. Herrmann: K. Storz (Consultant, Proctor), (Thieme. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
32. [Development of endoscopic enucleation of the prostate].
- Author
-
Gross AJ, Rosenbaum C, Becker B, and Netsch C
- Subjects
- Male, Humans, Laser Therapy methods, Prostate pathology, Prostate surgery, Prostatic Hyperplasia surgery, Endoscopy methods
- Abstract
This article deals with lasers from their initial description to the most advanced applications in the treatment of benign prostate enlargement., Competing Interests: Die Autorinnen/Autoren geben an, dass kein Interessenkonflikt besteht., (Thieme. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
33. [Prostate Surgery for Benign Prostatic Syndrome >200 ml: Endoscopic, Robotic, or Open Approach].
- Author
-
Hartung FO, Gruene B, Becker B, Rassweiler-Seyfried MC, Miernik A, Lusuardi L, Herrmann TR, Lehrich K, Netsch C, and Herrmann J
- Subjects
- Humans, Male, Prostate surgery, Prostate pathology, Minimally Invasive Surgical Procedures methods, Prostatic Hyperplasia surgery, Robotic Surgical Procedures methods, Prostatectomy methods, Endoscopy methods
- Abstract
Surgical approaches for benign prostatic hyperplasia have evolved and diversified over the past decades. While numerous studies document the efficacy of surgical procedures for moderate prostate sizes, there remains insufficient data for large prostate volumes >200 ml, leaving important questions unanswered regarding their effectiveness and safety. Consequently, selecting and adapting suitable therapeutic options for this specific patient group often poses a significant challenge. In this context, this review comprehensively summarizes and discusses current insights into surgical treatment options for large prostate volumes (>200 ml) following an extensive literature review.In summary, the surgical treatment of prostate volumes >200 ml is a challenge regardless of the chosen surgical method. Minimally invasive approaches should be considered standard practice today. Anatomical endoscopic enucleation of the prostate is a size-independent method and has the lowest morbidity. As it may be performed in spinal anaesthesia, endoscopic enucleation is feasible in patients with an increased anaesthetic risk. In extremely large prostate glands, the procedure poses challenges even for highly experienced surgeons. Especially in obese patients, the surgeon should be familiar with different exit strategies. Robot-assisted simple prostatectomy provides a minimally invasive alternative that may also treat pathologies such as diverticula or large bladder stones in the same surgical session. Due to its transabdominal approach, the morbidity and anaesthetic risk is comparatively higher. Each centre and surgeon should individually decide in which method they have the greatest expertise and which option is best suited for the specific case. In cases of limited expertise, it is advisable to refer patients to a centre with appropriate specialization., Competing Interests: Die Autorinnen/Autoren geben an, dass kein Interessenkonflikt besteht., (Thieme. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
34. [Thulium or holmium laser or both: where will the journey take us?]
- Author
-
Becker B, Hook S, Gross AJ, Rosenbaum C, Filmar S, Herrmann J, and Netsch C
- Subjects
- Humans, Male, Prostatectomy instrumentation, Prostatectomy methods, Lasers, Solid-State therapeutic use, Lithotripsy, Laser methods, Lithotripsy, Laser instrumentation, Thulium
- Abstract
The Holmium:YAG laser has been the gold standard for laser lithotripsy over the past three decades and, since the late 1990s, also for prostate enucleation. Pulsed thulium fibre lasers (TFL) demonstrated their efficacy in in-vitro experiments and were introduced to the market a few years ago. Initial clinical results for TFL in lithotripsy and enucleation are very promising. In addition to TFL, a pulsed Thulium:YAG solid-state laser has been introduced, but clinical data for this laser are currently limited. This article aims to review the key technological differences between Ho:YAG lasers and pulsed thulium lasers and compare/discuss the initial clinical results for stone lithotripsy and laser enucleation.In-vitro studies have demonstrated the technical superiority of TFL compared with Ho:YAG lasers. However, as TFL is still a new technology, only limited studies are available to date, and optimal settings for lithotripsy have not been established. For enucleation, the differences of TFL compared with a high-power Ho:YAG laser seem to be clinically irrelevant. Initial studies on pulsed Tm:YAG lasers show good results, but there continues to be a lack of comparative studies.Based on the current literature, pulsed thulium lasers have the potential of being an alternative to Ho:YAG lasers. However, further studies are necessary to determine the optimal laser technology for enucleation and lithotripsy of urinary stones, considering all parameters, including efficacy, safety, and cost., Competing Interests: Die Autorinnen/Autoren geben an, dass kein Interessenkonflikt besteht., (Thieme. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
35. [Should we all switch to en-bloc resection of bladder tumours?]
- Author
-
Herrmann J, Hartung FO, Kriegmair MC, Becker B, Lusuardi L, Herrmann TRW, and Netsch C
- Subjects
- Humans, Urinary Bladder surgery, Urinary Bladder pathology, Neoplasm Recurrence, Local surgery, Cystoscopy, Urinary Bladder Neoplasms surgery, Urinary Bladder Neoplasms pathology, Cystectomy methods
- Abstract
In En-Bloc Resection of Bladder Tumours (ERBT), tumours are not removed in fragments, but are dissected in one layer and, if possible, extracted in one piece. This method represents a significant shift in the surgical management of non-muscle-invasive bladder tumours, providing multiple benefits over the traditional transurethral resection of the bladder (TUR-B). The histological analysis of ERBT specimens is more accurate, enhancing diagnostic precision. Additionally, the presence of detrusor muscle in ERBT specimens is more frequent, indicating a more complete removal of the tumours. Recent years have seen the consolidation of a robust evidence base emphasizing the advantages of ERBT. Notably, a multicentric, prospective randomized trial has recently revealed a significant reduction in recurrence rates at 12 months follow-up compared with TUR-B. Experienced endourologists should explore this technique, as it may soon become the standard of care. The technique's elegance and effectiveness make it too important to be ignored., Competing Interests: JH ist Proctor und Consultant für Boston Scientific. CN ist Proctor und Consultant für Richard Wolf., (Thieme. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
36. [How good are we really? Incidence of postoperative bleeding requiring intervention and intraoperative electrocoagulation during Thulium laser enucleation of the prostate].
- Author
-
Filmar S, Schaefer J, Gross AJ, Hook S, Mehrer F, Becker B, Rosenbaum C, and Netsch C
- Subjects
- Humans, Male, Aged, Retrospective Studies, Middle Aged, Laser Therapy, Prostatectomy methods, Lasers, Solid-State therapeutic use, Incidence, Prostate surgery, Prostatic Hyperplasia surgery, Postoperative Hemorrhage etiology, Electrocoagulation, Thulium
- Abstract
The need for intervention due to postoperative bleeding represents a significant complication in Thulium Laser Enucleation of the Prostate (ThuLEP). This study aimed to retrospectively analyse this complication in the treatment of benign prostatic enlargement. This study focuses on investigating potential causative factors for postoperative bleeding requiring intervention as well as the use of intraoperative electrocoagulation. A total of 503 ThuLEP procedures performed between 08/2021 and 07/2022 were examined. Postoperatively, 4.2% (n=21) of patients experienced bleeding requiring intervention. Study data revealed a significant association between these instances of bleeding and a high prostate volume (p=0.004), high enucleation weight (p=0.004), and intraoperative electrocoagulation (p=0.048). In total, intraoperative electrocoagulation was applied in 41.2% (n=207) of cases. In these cases, statistically significant factors leading to the application of electrocoagulation included intraoperative capsule perforation (p=0.005) and high enucleation weight (p=0.002)., Competing Interests: Die Autorinnen/Autoren geben an, dass kein Interessenkonflikt besteht., (Thieme. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
37. [Imaging in nephroureterolithasis].
- Author
-
Peters J, Oswald D, Eiben C, Ramesmayer C, Abenhardt M, Sieberer M, Homberg R, Gross AJ, Herrmann TRW, Miernik A, Becker B, Lehrich K, Klein JT, Hatiboglu G, Lusuardi L, and Netsch C
- Subjects
- Humans, Female, Pregnancy, Tomography, X-Ray Computed, Ureteroscopy methods, Kidney Calculi diagnostic imaging, Urolithiasis therapy, Urinary Diversion
- Abstract
In the acute diagnostics of a suspected nephroureterolithiasis, ultrasonography should be the examination modality of choice. In cases of suspected urolithiasis, unclear flank pain with fever or in cases of a solitary kidney, a noncontrast computed tomography (CT) scan should always subsequently be performed. If the sonography findings are inconclusive in pregnant women a magnetic resonance imaging (MRI) examination can be considered. If there are indications for urinary diversion, a retrograde imaging study should be performed as part of the urinary diversion. This or CT imaging is also suitable for preinterventional imaging before shock wave lithotripsy, percutaneous nephrolithotomy or ureteroscopy. Postinterventional imaging is not always necessary and sonography is often sufficient. In a conservative treatment approach an abdominal plain X‑ray can be used for follow-up assessment., (© 2024. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF
38. Experts' recommendations in laser use for the treatment of bladder cancer: a comprehensive guide by the European Section of Uro-Technology (ESUT) and Training and Research in Urological Surgery and Technology (TRUST)-Group.
- Author
-
Ortner G, Güven S, Somani BK, Nicklas A, Teoh JY, Goumas IK, Bach T, Sancha FG, Figueredo FCA, Kramer MW, Bozzini G, Ulvik Ø, Kallidonis P, Roche JB, Miernik A, Enikeev D, Vaddi CM, Bhojani N, Sountoulides P, Lusuardi L, Baard J, Gauhar V, Ahmed A, Netsch C, Gözen AS, Nagele U, Herrmann TRW, and Tokas T
- Subjects
- Humans, Lasers, Technology, Thulium therapeutic use, Urinary Bladder Neoplasms surgery, Aluminum, Yttrium
- Abstract
Purpose: To identify laser settings and limits applied by experts during laser vaporization (vapBT) and laser en-bloc resection of bladder tumors (ERBT) and to identify preventive measures to reduce complications., Methods: After a focused literature search to identify relevant questions, we conducted a survey (57 questions) which was sent to laser experts. The expert selection was based on clinical experience and scientific contribution. Participants were asked for used laser types, typical laser settings during specific scenarios, and preventive measures applied during surgery. Settings for a maximum of 2 different lasers for each scenario were possible. Responses and settings were compared among the reported laser types., Results: Twenty-three of 29 (79.3%) invited experts completed the survey. Thulium fiber laser (TFL) is the most common laser (57%), followed by Holmium:Yttrium-Aluminium-Garnet (Ho:YAG) (48%), continuous wave (cw) Thulium:Yttrium-Aluminium-Garnet (Tm:YAG) (26%), and pulsed Tm:YAG (13%). Experts prefer ERBT (91.3%) to vapBT (8.7%); however, relevant limitations such as tumor size, number, and anatomical tumor location exist. Laser settings were generally comparable; however, we could find significant differences between the laser sources for lateral wall ERBT (p = 0.028) and standard ERBT (p = 0.033), with cwTm:YAG and pulsed Tm:YAG being operated in higher power modes when compared to TFL and Ho:YAG. Experts prefer long pulse modes for Ho:YAG and short pulse modes for TFL lasers., Conclusion: TFL seems to have replaced Ho:YAG and Tm:YAG. Most laser settings do not differ significantly among laser sources. For experts, continuous flow irrigation is the most commonly applied measure to reduce complications., (© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF
39. Re: Holmium Laser Enucleation of the Prostate Is Associated with Complications and Sequelae Even in the Hands of an Experienced Surgeon Following Completion of the Learning Curve.
- Author
-
Netsch C
- Subjects
- Male, Humans, Prostate surgery, Learning Curve, Prostatectomy adverse effects, Treatment Outcome, Retrospective Studies, Lasers, Solid-State adverse effects, Prostatic Hyperplasia complications, Prostatic Hyperplasia surgery, Surgeons, Laser Therapy adverse effects
- Published
- 2024
- Full Text
- View/download PDF
40. Primary Whole-gland Ablation for the Treatment of Clinically Localized Prostate Cancer: A Focal Therapy Society Best Practice Statement.
- Author
-
Deivasigamani S, Kotamarti S, Rastinehad AR, Salas RS, de la Rosette JJMCH, Lepor H, Pinto P, Ahmed HU, Gill I, Klotz L, Taneja SS, Emberton M, Lawrentschuk N, Wysock J, Feller JF, Crouzet S, Kumar M P, Seguier D, Adams ES, Michael Z, Abreu A, Jack Tay K, Ward JF, Shinohara K, Katz AE, Villers A, Chin JL, Stricker PD, Baco E, Macek P, Ahmad AE, Chiu PKF, Crawford ED, Rogers CG, Futterer JJ, Rais-Bahrami S, Robertson CN, Hadaschik B, Marra G, Valerio M, Chong KT, Kasivisvanathan V, Tan WP, Lomas D, Walz J, Guimaraes GC, Mertziotis NI, Becher E, Finelli A, Kasraeian A, Lebastchi AH, Vora A, Rosen MA, Bakir B, Arcot R, Yee S, Netsch C, Meng X, de Reijke TM, Tan YG, Regusci S, Benjamin TGR, Olivares R, Noureldin M, Bianco FJ, Sivaraman A, Kim FJ, Given RW, Dason S, Sheetz TJ, Shoji S, Schulman A, Royce P, Shah TT, Scionti S, Salomon G, Laguna P, Tourinho-Barbosa R, Aminsharifi A, Cathelineau X, Gontero P, Stabile A, Grummet J, Ledbetter L, Graton M, Stephen Jones J, and Polascik TJ
- Subjects
- Male, Humans, Prostate-Specific Antigen, Retrospective Studies, Treatment Outcome, Prostatic Neoplasms surgery, Cryosurgery adverse effects
- Abstract
Context: Whole-gland ablation is a feasible and effective minimally invasive treatment for localized prostate cancer (PCa). Previous systematic reviews supported evidence for favorable functional outcomes, but oncological outcomes were inconclusive owing to limited follow-up., Objective: To evaluate the real-world data on the mid- to long-term oncological and functional outcomes of whole-gland cryoablation and high-intensity focused ultrasound (HIFU) in patients with clinically localized PCa, and to provide expert recommendations and commentary on these findings., Evidence Acquisition: We performed a systematic review of PubMed, Embase, and Cochrane Library publications through February 2022 according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) statement. As endpoints, baseline clinical characteristics, and oncological and functional outcomes were assessed. To estimate the pooled prevalence of oncological, functional, and toxicity outcomes, and to quantify and explain the heterogeneity, random-effect meta-analyses and meta-regression analyses were performed., Evidence Synthesis: Twenty-nine studies were identified, including 14 on cryoablation and 15 on HIFU with a median follow-up of 72 mo. Most of the studies were retrospective (n = 23), with IDEAL (idea, development, exploration, assessment, and long-term study) stage 2b (n = 20) being most common. Biochemical recurrence-free survival, cancer-specific survival, overall survival, recurrence-free survival, and metastasis-free survival rates at 10 yr were 58%, 96%, 63%, 71-79%, and 84%, respectively. Erectile function was preserved in 37% of cases, and overall pad-free continence was achieved in 96% of cases, with a 1-yr rate of 97.4-98.8%. The rates of stricture, urinary retention, urinary tract infection, rectourethral fistula, and sepsis were observed to be 11%, 9.5%, 8%, 0.7%, and 0.8%, respectively., Conclusions: The mid- to long-term real-world data, and the safety profiles of cryoablation and HIFU are sound to support and be offered as primary treatment for appropriate patients with localized PCa. When compared with other existing treatment modalities for PCa, these ablative therapies provide nearly equivalent intermediate- to long-term oncological and toxicity outcomes, as well as excellent pad-free continence rates in the primary setting. This real-world clinical evidence provides long-term oncological and functional outcomes that enhance shared decision-making when balancing risks and expected outcomes that reflect patient preferences and values., Patient Summary: Cryoablation and high-intensity focused ultrasound are minimally invasive treatments available to selectively treat localized prostate cancer, considering their nearly comparable intermediate- to long term cancer control and preservation of urinary continence to other radical treatments in the primary setting. However, a well-informed decision should be made based on one's values and preferences., (Published by Elsevier B.V.)
- Published
- 2023
- Full Text
- View/download PDF
41. [Randomised comparison of different exit strategies in hydrocele resection].
- Author
-
Filmar S, Gross A, Netsch C, Rosenbaum C, and Becker B
- Abstract
Introduction: Adult hydrocele is a benign enlargement of the scrotum seen in approximately 60/100,000 men >18 years of age. Surgical resection of the hydrocele has been established as the gold standard for the treatment of symptomatic hydroceles. Postoperative complications are common with this surgery. Due to the lack of guidelines for the therapy of hydrocele, treatment is based primarily on clinical experience. The aim of the study was to conduct a randomised study on the influence of drains on complications in hydrocele resection according to von Bergmann., Material and Methods: A total of 60 patients were prospectively randomised into three groups. The groups each received an Easy-Flow drainage, a Cuti-Med Sorbact drainage, or no drainage. Haematoma and swelling, postoperative bleeding, infection, epididymal injury and revision surgery were clinically diagnosed as complications., Results: A complication was observed in 31.6% (n=19/60) of all patients. The complication rate was 50% (n=10) for the easy-flow drainage, 30% (n=6) for the Cuti-Med-Sorbact and 15% (n=3) for the group without drainage. Overall, a haematoma with swelling was observed most frequently, in 20% (n=12) of the cases. Revision surgery was required in 5% (n=3) of cases. Epididymal injuries were found histologically in 10% (n=6). Comparing the collective with the Easy-Flow drainage with the collective without drainage, the occurrence of complications was observed significantly more frequently in the drainage group (p<0.018). A statistically significant correlation regarding complications between the group of Cuti-Med-Sorbact and no drainage could not be shown (p<0.25)., Conclusions: Hydrocele resection is a complicated procedure. Based on the data presented here, the insertion of a drain is associated with an increased risk of postoperative complications. If the decision to insert a wound drainage is made intraoperatively, the Cuti-Med-Sorbact drainage appears to be associated with fewer complications., Competing Interests: Die Autorinnen/Autoren geben an, dass kein Interessenkonflikt besteht., (Thieme. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
42. Experts' recommendations in laser use for the endoscopic treatment of prostate hypertrophy: a comprehensive guide by the European Section of Uro-Technology (ESUT) and Training-Research in Urological Surgery and Technology (T.R.U.S.T.)-Group.
- Author
-
Ortner G, Güven S, Somani BK, Nicklas A, Scoffone CM, Gracco C, Goumas IK, Bach T, Sancha FG, Figueredo FCA, Krambeck A, Bozzini G, Lehrich K, Liatsikos E, Kallidonis P, Roche JB, Miernik A, Enikeev D, Tunc L, Bhojani N, Gilling P, Otero JR, Porreca A, Ahyai S, Netsch C, Gözen AS, Nagele U, Herrmann TRW, and Tokas T
- Subjects
- Male, Humans, Prostate, Hypertrophy drug therapy, Hypertrophy surgery, Thulium therapeutic use, Lithotripsy, Laser methods, Prostatic Hyperplasia surgery, Prostatic Hyperplasia drug therapy, Lasers, Solid-State therapeutic use, Laser Therapy methods
- Abstract
Purpose: To identify expert laser settings for BPH treatment and evaluate the application of preventive measures to reduce complications., Methods: A survey was conducted after narrative literature research to identify relevant questions regarding laser use for BPH treatment (59 questions). Experts were asked for laser settings during specific clinical scenarios. Settings were compared for the reported laser types, and common settings and preventive measures were identified., Results: Twenty-two experts completed the survey with a mean filling time of 12.9 min. Ho:YAG, Thulium fiber laser (TFL), continuous wave (cw) Tm:YAG, pulsed Tm:YAG and Greenlight™ lasers are used by 73% (16/22), 50% (11/22), 23% (5/22), 13.6% (3/22) and 9.1% (2/22) of experts, respectively. All experts use anatomical enucleation of the prostate (EEP), preferentially in one- or two-lobe technique. Laser settings differ significantly between laser types, with median laser power for apical/main gland EEP of 75/94 W, 60/60 W, 100/100 W, 100/100 W, and 80/80 W for Ho:YAG, TFL, cwTm:YAG, pulsed Tm:YAG and Greenlight™ lasers, respectively (p = 0.02 and p = 0.005). However, power settings within the same laser source are similar. Pulse shapes for main gland EEP significantly differ between lasers with long and pulse shape modified (e.g., Moses, Virtual Basket) modes preferred for Ho:YAG and short pulse modes for TFL (p = 0.031)., Conclusion: Ho:YAG lasers no longer seem to be the mainstay of EEP. TFL lasers are generally used in pulsed mode though clinical applicability for quasi-continuous settings has recently been demonstrated. One and two-lobe techniques are beneficial regarding operative time and are used by most experts., (© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
- Published
- 2023
- Full Text
- View/download PDF
43. [First-line treatment of metastatic renal cell carcinoma].
- Author
-
Bruchbacher A, Netsch C, and Gross AJ
- Subjects
- Humans, Protein Kinase Inhibitors therapeutic use, Immunotherapy, Combined Modality Therapy, Carcinoma, Renal Cell drug therapy, Kidney Neoplasms drug therapy
- Abstract
In recent years the first-line treatment of metastatic renal cell carcinoma was revolutionized by the introduction of checkpoint inhibitors (CPI). Within a few years several combined modality treatments with CPI and tyrosine kinase inhibitors (TKI) have proven to be effective and safe in the application. According to the guidelines, up to five different combined modality treatments can now be considered, depending on the risk profile. Based on the current data situation, a direct distinction between the treatments cannot be made as no comparative studies are available. Therefore, the decision for a particular treatment is often guided by individual factors. In particular, a clear processing of the patient with the respective risk factors and tumor identity is essential. Hence, it is all the more important to discuss complex cases in an interdisciplinary tumor board., (© 2023. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.)
- Published
- 2023
- Full Text
- View/download PDF
44. [Skin manifestations of the external male genitals].
- Author
-
Hook S, Gross AJ, Becker M, Netsch C, Rosenbaum C, and Becker B
- Subjects
- Male, Humans, Genitalia, Male pathology, Penile Neoplasms pathology, Skin Neoplasms, Lichen Sclerosus et Atrophicus pathology, Sexually Transmitted Diseases complications
- Abstract
The urological examination includes the inspection of the external male genitals. Harmless normal variants, such as heterotopic sebaceous glands and pearly penile papules must be differentiated from malignant and infectious manifestations. Lichen sclerosus et atrophicus is a frequent connective tissue disease that can lead to functional impairments and an associated high level of suffering for those affected. Both conservative and invasive treatment options are available. Sexually transmitted diseases, such as syphilis, are gaining increasing importance in routine clinical and daily practice due to the increasing incidence in recent years. An early diagnosis and treatment of malignant neoplasms, such as Queyrat's erythroplasia can be carried out by routine inspection of the genital skin., (© 2023. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.)
- Published
- 2023
- Full Text
- View/download PDF
45. First Clinical Experience of a Novel Pulsed Solid-State Thulium:YAG Laser during Percutaneous Nephrolithotomy.
- Author
-
Bergmann J, Rosenbaum CM, Netsch C, Gross AJ, and Becker B
- Abstract
Introduction: Laser lithotripsy during Mini-PCNL is one treatment option in urinary stone disease. In recent years, a new era in stone treatment has been initiated with the introduction of new pulsed thulium lasers. The aim of this study was to investigate the safety and efficacy of laser lithotripsy with a new pulsed solid-state thulium:YAG laser during mini-PCNL., Materials and Methods: All patients, regardless of stone size, who were treated with a Mini-PCNL using the new pulsed thulium laser were prospectively enrolled. Operation times, stone size, laser time, and laser settings were noted. The stone-free rate was assessed postoperatively with sonography and either X-ray or computed tomography as a clinical standard. The complications were analyzed using the Clavien-Dindo classification., Results: A total of 50 patients with a mean age of 52 years were included. 31 (62 %) patients were male. The average stone size was 242.3 (±233.1) mm
2 with an average density of 833 (±325) Hounsfield units. The mean operating time was 30.56 (±28.65) min, and the laser-on-time was 07:07 (± 07:08) min. The most commonly used settings were 0.4 J and 115 Hz (46 W). The mean total energy for stone ablation was 14,166 (±17,131) kJ. The total stone-free rate was 84 %, with an overall complication rate of 32% according to Clavien-Dindo (grade 1: n = 9, grade 2: n = 6, 3b: n = 1). In the group of patients with singular stones (n = 25), the stone-free rate was 88%., Summary: The new pulsed solid-state Thulium:YAG laser allows a safe and effective lithotripsy during Mini-PCNL. The stone-free rates were high regardless of stone size with a comparable low rate of complications.- Published
- 2023
- Full Text
- View/download PDF
46. Influence of Prostate Cancer on Thulium Vapoenucleation of the Prostate-A Multicentre Analysis.
- Author
-
Lamersdorf T, Netsch C, Becker B, Wülfing C, Anheuser P, Engel O, Gross AJ, and Rosenbaum CM
- Abstract
Purpose: Prostate cancer (PCa) and benign prostatic hyperplasia (BPH) are common in elderly men. Data on the laser-based surgery known as thulium vapoenucleation of the prostate (ThuVEP) in PCa patients are rare. Our objective was to analyse the feasibility, safety and functional outcome of ThuVEP in patients with lower urinary tract symptoms (LUTS) and PCa. Methods: Multicentre study, including 1256 men who underwent ThuVEP for LUTS. Maximum urinary flow rate (Qmax) and post-void residual volume (PVR) were measured perioperatively. The International Prostate Symptome Score (IPSS) was measured perioperatively and at follow-up (FU). Perioperative complications were captured. Reoperation rate was captured at FU. Results: Of 994 men with complete data, 286 (28.8%) patients had PCa. The most common Gleason score was 3 + 3 in 142 patients (49.7%). Most common was low-risk PCa (141 pts; 49.3%). PCa patients were older, had smaller prostates and had higher prostate-specific antigen (PSA) values (all p < 0.001). Comparing non-PCa and PCa patients, no differences occurred perioperatively. IPSS, quality of life and PVR decreased (all p < 0.001) and Qmax improved ( p < 0.001) in both groups. Reoperation rates did not differ. The results of low- vs. intermediate-/high-risk PCa patients were comparable. Conclusion: ThuVEP is a safe and long-lasting treatment option for patients with LUTS with or without PCa. No differences occurred when comparing low- to intermediate-/high-risk PCa patients., Competing Interests: The authors declare no conflict of interest.
- Published
- 2023
- Full Text
- View/download PDF
47. [Processing of medical products in the urological practice].
- Author
-
Ebner W, Bauer M, Sigle A, Miernik A, Becker B, Lehrich K, Klein JT, Lusuardi L, Gross AJ, Herrmann TRW, Frede T, Siegsmund M, Netsch C, Gratzke C, and Schoeb DS
- Subjects
- Hospitals, Endoscopy, Equipment and Supplies, Hygiene, Sterilization, Cross Infection prevention & control
- Abstract
The reprocessing of medical products is an important topic both in urological practices and in hospitals. The complexity is caused by the increasing variety of medical instruments and also by the increasing demands on the legally required quality of the reprocessing. The Robert Koch Institute (RKI) and the Federal Institute for Drugs and Medical Devices (BfArM) have published recommendations for the processing of MD and last updated them in 2012. This article summarizes the legal framework for the reprocessing of medical devices, how medical devices are categorized before the appropriate procedure for reprocessing can be selected and the various steps in the reprocessing. A special focus is placed on medical products that are typically found in urological practices or outpatient departments and are processed there. Furthermore, the necessity of validating the processing method and the required training (expertise) of the personnel are discussed., (© 2023. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.)
- Published
- 2023
- Full Text
- View/download PDF
48. Thulium YAG is the Best Laser for the Prostate Because of Versatility.
- Author
-
Herrmann TRW, Becker B, and Netsch C
- Published
- 2022
- Full Text
- View/download PDF
49. Long-term evaluation of outcomes and costs of urolithiasis re-interventions after ureteroscopy, extracorporeal shockwave lithotripsy and percutaneous nephrolithotomy based on German health insurance claims data.
- Author
-
Konnopka C, Becker B, Netsch C, Herrmann TRW, Gross AJ, Lusuardi L, Knoll T, and König HH
- Subjects
- Humans, Ureteroscopy, Retrospective Studies, Insurance, Health, Treatment Outcome, Nephrolithotomy, Percutaneous, Lithotripsy, Urolithiasis surgery, Kidney Calculi surgery
- Abstract
Purpose: Comparisons of ureteroscopy (URS), extracorporeal shockwave lithotripsy (SWL) and percutaneous nephrolithotomy (PCNL) for urolithiasis considering long-term follow-up are rare. We aimed to analyze re-intervention rates, costs and sick leave days of URS, SWL and PCNL patients within 7 years., Methods: This retrospective cohort study was based on German health insurance claims data. We included 54,609 urolithiasis patients incidentally treated in 2008-2010. We investigated time to re-intervention, number of sick leave days and healthcare costs. We applied negative binomial, extended Cox regression and gamma models., Results: 54% were incidentally treated with URS, 40% with SWL and 6% with PCNL. 15% of URS, 26% of SWL and 23% of PCNL patients were re-treated within 7 years. Time to re-intervention was significantly lower for PCNL (955 days) and SWL (937 days) than URS (1078 days) patients. Costs for incident treatment were significantly higher for PCNL (2760€) and lower for SWL (1342€) than URS (1334€) patients. Yet, total costs including re-interventions were significantly higher for PCNL (5783€) and SWL (3240€) than URS (2979€) patients. Total number of sick leave days was increased for PCNL (13.0 days) and SWL (10.1 days) compared to URS (6.8 days) patients., Conclusion: This study describes outcomes after use of different intervention options for urolithiasis. URS patients showed longest time free of re-interventions and lowest number of sick leave days. Although SWL patients initially had lower costs, URS patients had lower costs in the long run. PCNL patients showed high costs and sick leave days., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
50. [Image-guided biopsy of the prostate gland].
- Author
-
Sigle A, Michaelis J, Schöb D, Benndorf M, Schimmöller L, Becker B, Pallauf M, Gross AJ, Herrmann TRW, Klein JT, Lusuardi L, Netsch C, Häcker A, Westphal J, Jilg C, Gratzke C, and Miernik A
- Subjects
- Humans, Image-Guided Biopsy methods, Male, Prostate diagnostic imaging, Ultrasonography, Interventional methods, Magnetic Resonance Imaging, Interventional methods, Prostatic Neoplasms diagnostic imaging
- Abstract
The recommendations on carrying out a multiparametric magnetic resonance imaging (mpMRI) for the primary diagnostics and during active surveillance of prostate cancer, include as a consequence an image-guided sampling from conspicuous areas. In doing so, the information on the localization provided by mpMRI is used for a targeted biopsy of the area suspected of being a tumor. The targeted sampling is mainly performed under sonographic control and after fusion of MRI and ultrasound but can also be (mostly in special cases) carried out directly in the MRI scanner. In an ultrasound-guided biopsy, it is vital to coregister the MR images with the ultrasound images (segmentation of the contour of the prostate and registration of suspect findings). This coregistration can either be carried out cognitively (transfer by the person performing the biopsy alone) or software based. Each method shows specific advantages and disadvantages in the prioritization between diagnostic accuracy and resource expenditure., (© 2022. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.)
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.